Stand Up To Cancer’s Health Equity Initiative aims to improve disparities in cancer research, screening and treatment.
Communities of diverse race and ethnicity, as well as people living in rural communities, are frequently underserved by the health care system. This can result in poorer health outcomes, which is the case with cancer much too often. The conditions in which people live, work, learn and play, as well as mistrust or fear of the healthcare system or language and financial barriers, can also contribute to disparities in cancer research, screening and outcomes.
SU2C is tackling this issue by mandating that our research addresses the recruitment and retention of medically underserved communities in cancer clinical trials. We’re also spearheading several research, education and cancer screening efforts, and encouraging other funders and research entities to take similar steps. All with the shared goal of achieving equity for all cancer patients.
“Cancer research has made tremendous progress but has not benefited all patients equitably. It is incumbent upon the medical community to ensure that new treatments are available and effective for all, and one of the key pieces to accomplishing that aim is to ensure diversity in clinical trials.”
—Edith Perez, Chair of the Health Equity Committee
Cancer research is more effective for all when representation and access to breakthrough treatments is prioritized and barriers to access are considered or removed.
This is why, since January 2020, all SU2C-supported research grant proposals address the recruitment and retention of patients from medically underserved communities in cancer clinical trials, as part of our Health Equity Initiative. We’re also committed to ensuring diverse and rural communities have the opportunity to receive the newest treatments and lifesaving screenings.
For true breakthroughs to be made, diverse representation must be prioritized at every step of the journey.
Timeline of Achievements in Health Equity
SU2C began developing its Health Equity Initiative in 2017. The initiative is guided by SU2C’s Committee for Health Equity in Cancer Clinical Trials, which was formed in 2018. The Health Equity Initiative was formally announced in January 2020 during SU2C's annual Scientific Summit. To date, we’ve made significant progress:
SU2C launches first Clinical Trials PSA featuring Sonequa Martin-Green to share the importance of diverse participation in clinical trials
SU2C announces Health Equity Initiative
Second Clinical Trials PSA features Jaime Camil
SU2C receives grant from Bristol Myers Squibb focused on improving health equity for underserved lung cancer patients
Third Clinical Trials PSA features Cedric the Entertainer
Sharp Tank Award goes to research focused on health disparities in multiple myeloma
SU2C receives grant from Exact Sciences to focus on colorectal cancer health equity research and screening education efforts
SU2C and Exact Sciences PSA features Jamie Foxx and raises awareness for colorectal cancer screening and disparities
SU2C announces Health Equity Breakthrough Team focused on increasing diversity in cancer clinical trials
SU2C announces Colorectal Cancer Health Equity Dream Team focused on increasing colorectal cancer screenings in medically underserved communities
Drag to advance the timeline
Awareness & Education
One of the three core pillars of Stand Up To Cancer’s Health Equity Initiative is awareness and education around diversity in cancer research, treatment and prevention.
These efforts promote clinical trials as one of the ways to access the most advanced treatments and they also include information on the importance of cancer prevention via timely and consistent cancer screenings.
Science & Research
The second pillar focuses on science and research. SU2C is dedicated to funding research that is focused on screening and bringing diverse patients into the research and clinical trial process.
SU2C’s Health Equity Committee has developed high standards to solicit proposals from prospective researchers in order to increase diverse participation in cancer clinical trials. We have also funded research projects that are specific to underserved communities.
The final pillar involves advocacy and collaborations. SU2C is committed to joining forces with various advocacy organizations to ensure the communities they serve know how to get involved in cancer research, and have access to preventative screenings.
As a leading funder of cancer research, SU2C is taking tangible steps to improve health equity and setting standards that we hope others adopt to increase diverse participation in cancer clinical trials.